FOLD
Price
$9.78
Change
+$0.05 (+0.51%)
Updated
Dec 3 closing price
Capitalization
3.02B
77 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$11.97
Change
+$0.84 (+7.55%)
Updated
Dec 3 closing price
Capitalization
1.04B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FOLD vs KURA

Header iconFOLD vs KURA Comparison
Open Charts FOLD vs KURABanner chart's image
Amicus Therapeutics
Price$9.78
Change+$0.05 (+0.51%)
Volume$2.92M
Capitalization3.02B
Kura Oncology
Price$11.97
Change+$0.84 (+7.55%)
Volume$1.45M
Capitalization1.04B
FOLD vs KURA Comparison Chart in %
View a ticker or compare two or three
VS
FOLD vs. KURA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a StrongBuy and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (FOLD: $9.73 vs. KURA: $11.15)
Brand notoriety: FOLD and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 33% vs. KURA: 34%
Market capitalization -- FOLD: $3.02B vs. KURA: $1.04B
FOLD [@Biotechnology] is valued at $3.02B. KURA’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, KURA is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 2 TA indicator(s) are bullish while KURA’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 2 bullish, 4 bearish.
  • KURA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KURA is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а -1.42% price change this week, while KURA (@Biotechnology) price change was -3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 19, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($3.02B) has a higher market cap than KURA($1.04B). KURA YTD gains are higher at: 28.014 vs. FOLD (3.291). FOLD has higher annual earnings (EBITDA): 33.1M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. FOLD (231M). KURA has less debt than FOLD: KURA (19.5M) vs FOLD (443M). FOLD has higher revenues than KURA: FOLD (571M) vs KURA (83.3M).
FOLDKURAFOLD / KURA
Capitalization3.02B1.04B290%
EBITDA33.1M-192.46M-17%
Gain YTD3.29128.01412%
P/E RatioN/AN/A-
Revenue571M83.3M685%
Total Cash231M631M37%
Total Debt443M19.5M2,272%
FUNDAMENTALS RATINGS
FOLD vs KURA: Fundamental Ratings
FOLD
KURA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
4037
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (33) in the Biotechnology industry is in the same range as FOLD (56). This means that KURA’s stock grew similarly to FOLD’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that KURA’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's SMR Rating (95) in the Biotechnology industry is in the same range as KURA (97). This means that FOLD’s stock grew similarly to KURA’s over the last 12 months.

KURA's Price Growth Rating (37) in the Biotechnology industry is in the same range as FOLD (40). This means that KURA’s stock grew similarly to FOLD’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that KURA’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FOLDKURA
RSI
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 7 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 7 days ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 7 days ago
72%
Advances
ODDS (%)
Bullish Trend 11 days ago
69%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 28 days ago
75%
N/A
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIFPX25.50N/A
N/A
Fidelity Advisor Founders M
FNDMX13.72N/A
N/A
Fidelity Series Sust Non-US Dev Mrkt Fd
HDVCX15.16N/A
N/A
Hartford International Equity C
MFRFX64.85N/A
N/A
MFS Research A
BINSX14.96N/A
N/A
Baillie Gifford International Alpha I

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with RARE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.71%
RARE - FOLD
45%
Loosely correlated
+0.28%
XNCR - FOLD
45%
Loosely correlated
-3.15%
BMRN - FOLD
44%
Loosely correlated
-2.07%
KURA - FOLD
44%
Loosely correlated
-2.53%
CLDX - FOLD
44%
Loosely correlated
+2.85%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.53%
XNCR - KURA
58%
Loosely correlated
-3.15%
CLDX - KURA
53%
Loosely correlated
+2.85%
RGNX - KURA
53%
Loosely correlated
-3.10%
IMTX - KURA
51%
Loosely correlated
-3.70%
DYN - KURA
48%
Loosely correlated
-2.96%
More